ACTRN12620000773932终止未知
A Safety and Technical Feasibility Evaluation of the Arterica Closure Device for Large-Bore Vascular Closure Following Interventional Procedures
Arterica, Inc.0 个研究点目标入组 4 人开始时间: 2020年7月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 终止
- 发起方
- 入组人数
- 4
研究概览
简要总结
As a first-in-human study the study is a safety and technical evaluation. The primary safety endpoint was evaluated at 30 days post procedure and looked at major complications from the study device. The technical success endpoint was evaluated immediately post procedure and looked at the device ability to close the artery. There were 4 study participants enrolled, with a total of 7 procedures completed using the device, since 3 of the 4 subjects had 2 sites requiring closure. All participants were male, over the age of 70. For the technical feasibility endpoint, 6 of 7 procedures met the study definition of technical success. For the safety endpoint, there was 1 SAE related to the study device.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit(—)
- 性别
- All
入选标准
- •Subject is >18 years of age at time of consent
- •Subject is scheduled for elective or planned (i.e., not emergent or urgent) percutaneous transcatheter interventional procedures involving access through the common femoral artery
排除标准
- •Subject is pregnant or lactating
- •Subject has known bleeding disorder
- •Subject has recent history of common femoral artery closure with any common femoral artery closure device or any open procedure in the target groin.
- •Subject has recent history of common femoral artery closure with manual compression.
- •Subject unable to ambulate.
- •Subject has a unilateral or bilateral lower extremity amputation
研究者
相似试验
已完成
不适用
NitiNotes' EndoZip System for the Treatment of ObesityObesityNCT03472196Nitinotes Surgical Ltd.14
招募中
1 期
This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.Hematologic MalignanciesNCT06756451Nanjing RegeneCore Biotech Co., Ltd.71
Unknown
不适用
Robotic-assisted Percutaneous Transhepatic PunctureLiver DiseasesNCT06195917Zhongda Hospital20
尚未招募
Unknown
Embolisation with NeoCast for Chronic Subdural HematomaeurologicalNeurologicalNeurological - Other neurological disordersACTRN12624000659505Arsenal Medical Australia Pty Ltd.10
招募中
1 期
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid TumorsAdvanced Solid TumorNCT05007782Gilead Sciences416
